Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on May 29, 2002

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your 

correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
00N-1525 Debarment of Richard Elliott Humphreys;Notice of Opportunity *
02N-0169 Combination Products Containing Live Cellular Components *
02P-0244 Warning Statement for All HMG Co-A Reductase Inhibitors *
02P-0245 ANDA for Fludarabine Phosphate Injection, 25 mg/ML *

76N-052N OTC Nasal Decongestants

EMC 128 Michael J. Norlien Vol#: 7

97P-0329 Require Quantitative Labeling of Caffeine Content

EMC 5 Sara E. Firebaugh Vol#: 4

97P-0498 Label foods & beverages containing greater than 5mg caffeine

EMC 3 Scott Firebaugh Vol#: 1

00D-1542 Electronic Signatures: Time Stamps

EMC 2 American Assn of Blood Banks Vol#: 1

EMC 3 Triangle PEERS Vol#: 1

00D-1598 Voluntary Labeling for Bioengineered Foods

EMC 11867 Marilyn Carr Vol#: 426

EMC 11868 Amanda Marsh Vol#: 426

EMC 11869 Patricia M. Cooke Vol#: 426

00N-1525 Debarment of Richard Elliott Humphreys;Notice of Opportunity

WDL 1 HFD-1 Vol#: 1

00P-1322 Food Labeling and Allergen Contamination Control

EMC 482 No signature Vol#: 20

EMC 483 Mary Allen Sawtelle Vol#: 20

01N-0067 Reclassification of Dental Mercury

EMC 10 Lori & Mark May Vol#: 2

EMC 11 Murlene Brake Vol#: 2

EMC 12 Leonard S. Rosenbaum Vol#: 2

EMC 13 Janie McDowell Vol#: 2

EMC 14 Dr. Alice Baldwin Vol#: 2

EMC 15 Claes Molius Vol#: 2

EMC 16 Camilla Rees Vol#: 2

EMC 17 Murlene Brake Vol#: 2

EMC 18 Salman Rushdie Vol#: 2

EMC 19 Charlie Norris Vol#: 2

EMC 20 Karen Truskowski Vol#: 2

EMC 21 Jack & Arlene Cross Vol#: 2

EMC 22 Boyd E. Haley Vol#: 2

EMC 23 Sue Ann Taylor Vol#: 2

EMC 24 Jane Haley Vol#: 2

EMC 25 Joyce Van Haaften Vol#: 2

EMC 26 Virginia Barber Vol#: 2

EMC 27 Doreen Randal Vol#: 2

EMC 28 Andrew Hall Cutler, PhD Vol#: 2

EMC 29 Carol J. Ward Vol#: 2

EMC 30 Rita Joyce, RN Vol#: 2

EMC 31 Jake Vandersys Vol#: 2

EMC 32 Patrick Quillin, PhD, RD, CNS Vol#: 2

EMC 33 Andrew Hall Cutler, PhD Vol#: 2

EMC 34 Joan Murphy, PhD Vol#: 2

EMC 35 Andrew Hall Cutler, PhD Vol#: 2

EMC 36 Vito Minielli Vol#: 2

EMC 37 Theresa Bevins, RDH Vol#: 2

EMC 38 David Kennedy, DDS Vol#: 2

EMC 39 Linda M. Brocato Vol#: 2

EMC 40 Linda M. Brocato Vol#: 2

EMC 41 Darleen R. Johnson Vol#: 2

EMC 42 Elizabeth A. Goldblatt, PhD, M.P.A./H.A. Vol#: 2

EMC 43 Dexter Strawther Vol#: 2

EMC 44 Mary Ann Newell Vol#: 2

EMC 45 Adrian Chang Vol#: 2

EMC 46 Kristen Chase Lauter Vol#: 2

EMC 47 Bernard Windham Vol#: 2

EMC 48 James E. Rota, DDS Vol#: 2

EMC 49 Dr. Alice Baldwin Vol#: 2

EMC 50 Craig Geiger Vol#: 2

EMC 51 Andrew J. Duffy Vol#: 2

EMC 52 Don Steinke Vol#: 2

01P-0230 Domestic Marketing & Importation of Transgenic Fish

EMC 1965 Tim Daniels Vol#: 192

02N-0159 Focus Groups as used by the Food and Drug Administration

N 1 Vol#: 1

02N-0169 Combination Products Containing Live Cellular Components

APE 2 Novartis Pharmaceuticals Vol#: 2

LET 1 Novartis Pharmaceuticals Vol#: 1

02P-0244 Warning Statement for All HMG Co-A Reductase Inhibitors

ACK 1 HFA-305 Vol#: 1

CP 1 Dr. Julian M. Whitaker, M.D. Vol#: 1

02P-0245 ANDA for Fludarabine Phosphate Injection, 25 mg/ML

ACK 1 HFA-305 Vol#: 1

CP 1 Gensia Sicor Pharmaceuticals, Inc. Vol#: 1